Literature DB >> 9088950

Comparison of chromosome 1 aneusomy detected by interphase cytogenetics and DNA ploidy in carcinoma of the breast.

M M Harrison1, H M Magee, J F O'Loughlin, T F Gorey, J D Coyne, P A Dervan.   

Abstract

Aneuploidy is an important prognostic factor in many cancers. Chromosome 1 abnormalities are present in most breast carcinomas. These may be part of a non-specific increase in DNA (aneuploid status) or represent a restricted chromosomal abnormality. In 16 breast carcinomas we compared chromosome 1 aneusomy with ploidy status. Patients were selected from a mammographically screened population and interphase tumour nuclei were studied by in situ hybridization using a chromosome 1 pericentromeric probe. Ploidy status was assessed by image cytometry on disaggregated cells from paraffin blocks. Of eight cases showing chromosome 1 aneusomy, six (75%) were aneuploid and two diploid. Six (75%) of the eight eusomic cases were aneuploid. This study demonstrates that chromosome 1 aneusomy does not always reflect a gross aneuploid status but, in some tumours, is part of a more restricted chromosomal abnormality. Interphase cytogenetics, possibly using a small panel of pericentromeric probes, may be more sensitive than DNA cytometry for detecting abnormal nuclear DNA content.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088950     DOI: 10.1046/j.1365-2559.1997.d01-591.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  2 in total

1.  Prognostic value of chromosome 1 and 8 copy number in invasive ductal breast carcinoma among Iranian women: an interphase FISH analysis.

Authors:  Farkhondeh Behjati; Morteza Atri; Hossein Najmabadi; Keramat Nouri; Mahdi Zamani; Parvin Mehdipour
Journal:  Pathol Oncol Res       Date:  2005-09-29       Impact factor: 3.201

2.  Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis.

Authors:  M C Cummings; M Aubele; A Mattis; D Purdie; P Hutzler; H Höfler; M Werner
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.